Cart
sales@molnova.com
MK-4827 hydrochloride
CAS No. 1038915-64-8
MK-4827 hydrochloride( Niraparib hydrochloride | MK 4827 hydrochloride | MK4827 hydrochloride )
Catalog No. M10195 CAS No. 1038915-64-8
A highly potent PARP inhibitor with IC50 of 3.8 nM/2.1 nM for PARP1/PARP2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 31 | In Stock |
|
| 5MG | 50 | In Stock |
|
| 10MG | 72 | In Stock |
|
| 25MG | 107 | In Stock |
|
| 50MG | 132 | In Stock |
|
| 100MG | 205 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameMK-4827 hydrochloride
-
NoteResearch use only, not for human use.
-
Brief DescriptionA highly potent PARP inhibitor with IC50 of 3.8 nM/2.1 nM for PARP1/PARP2.
-
DescriptionA highly potent PARP inhibitor with IC50 of 3.8 nM/2.1 nM for PARP1/PARP2; inhibits PARP activity with EC50=4 nM in a whole cell assay, and inhibits proliferation of cancer cells with mutant BRCA-1 and BRCA-2 with CC50 in the 10?100 nM range; well tolerated in vivo and demonstrates efficacy as a single agent in a xenograft model of BRCA-1 deficient cancer.Ovarian Cancer Approved.
-
In Vitro——
-
In Vivo——
-
SynonymsNiraparib hydrochloride | MK 4827 hydrochloride | MK4827 hydrochloride
-
PathwayCell Cycle/DNA Damage
-
TargetPARP
-
RecptorPARP
-
Research AreaCancer
-
IndicationOvarian Cancer
Chemical Information
-
CAS Number1038915-64-8
-
Formula Weight356.8492
-
Molecular FormulaC19H21ClN4O
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESC1CC(CNC1)C2=CC=C(C=C2)N3C=C4C=CC=C(C4=N3)C(=O)N.Cl
-
Chemical Name2H-Indazole-7-carboxamide, 2-[4-(3S)-3-piperidinylphenyl]-, hydrochloride (1:1)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Jones P, et al. J Med Chem. 2009 Nov 26;52(22):7170-85.
2. Bridges KA, et al. Oncotarget. 2014 Jul 15;5(13):5076-86.
3. Mirza MR, et al. N Engl J Med. 2016 Dec 1;375(22):2154-2164.
molnova catalog
related products
-
Fluzoparib
fluzoparib is a novel, potent, and orally available inhibitor of PARP, potentially for the treatment of solid tumours.Fluzoparib potently inhibited PARP1 enzyme activity and induced DNA double-strand breaks, G2 /M arrest, and apoptosis in homologous recombination repair (HR)-deficient cells.?
-
AG-14361
AG14361 is a potent inhibitor of PARP1 with Ki of <5 nM. It is at least 1000-fold more potent than the benzamides.
-
SRI-011381
SRI-011381, a new-type agonist of the TGF-beta signaling pathway, is utilized in the treatment of Alzheimer's disease.
